MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

Conditions: Unresectable Pleural Mesothelioma Interventions: Drug: Volrustomig; Drug: Pemetrexed; Drug: Carboplatin; Drug: Cisplatin; Drug: Nivolumab; Drug: Ipilimumab Sponsors: AstraZeneca Not yet recruiting

https://clinicaltrials.gov/study/NCT06097728

Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials